Premia Spine
PrivateLast Round
Early Funding
May 29, 2014
Total Funding Raised
$10M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Premia Spine is a medical technology company that develops and markets spinal implants as a motion-preserving alternative to fusion surgery for conditions like lumbar spinal stenosis and degenerative spondylolisthesis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Premia Spine Comparables
Compare Premia Spine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Companion Spine | 87% | |
| Centinel Spine | 84% | |
| Orthofix Medical Inc. | 72% | |
Premia Spine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 29, 2014 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open roles increased to 8, 8x the trailing average.
- Feb 29, 2024
Grew 16% QoQ, from 32 to 37 employees.
Premia Spine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Premia Spine's valuation, stock price, and market status.